Study Of CP-751,871 In Patients With Ewing's Sarcoma Family Of Tumors



Status:Completed
Conditions:Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:10 - Any
Updated:4/21/2016
Start Date:March 2008
End Date:October 2012

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

A Phase 1/Phase 2 Study Of CP-751,871 In Patients With Relapsed And/Or Refractory Ewing's Sarcoma Family Of Tumors

Define the efficacy of CP-751,871 in patients with Ewing's sarcoma family of tumors


Inclusion Criteria:

- Ewing's family of tumors

- Current disease state for which there is no curative therapy

Exclusion Criteria:

- Prior anti-IGF-1R therapy

- Concurrent treatment with other anti-cancer agents
We found this trial at
10
sites
Pfizer Investigational Site
Providence, Rhode Island 02905
?
mi
from
Providence, RI
Click here to add this to my saved trials
Pfizer Investigational Site
Boston, Massachusetts 02115
?
mi
from
Boston, MA
Click here to add this to my saved trials
Pfizer Investigational Site
Brisbane, Queensland
?
mi
from
Brisbane,
Click here to add this to my saved trials
Pfizer Investigational Site
Dallas, Texas 75204
?
mi
from
Dallas, TX
Click here to add this to my saved trials
Pfizer Investigational Site
Memphis, Tennessee 38103
?
mi
from
Memphis, TN
Click here to add this to my saved trials
Pfizer Investigational Site
New York, New York 10029
?
mi
from
New York, NY
Click here to add this to my saved trials
Pfizer Investigational Site
Philadelphia, Pennsylvania 19134
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pfizer Investigational Site
Rochester, Minnesota 55905
?
mi
from
Rochester, MN
Click here to add this to my saved trials
Pfizer Investigational Site
Seattle, Washington 98166
?
mi
from
Seattle, WA
Click here to add this to my saved trials
Pfizer Investigational Site
Tampa, Florida 33609
?
mi
from
Tampa, FL
Click here to add this to my saved trials